What are the symptoms of QTc prolongation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Symptoms of QTc Prolongation

QTc prolongation itself is typically asymptomatic, but when it triggers life-threatening arrhythmias—specifically torsades de pointes (TdP) and ventricular fibrillation—patients present with syncope, seizures, sudden cardiac arrest, or sudden death. 1

Clinical Presentations to Recognize

The 2023 Canadian Cardiovascular Society guidelines emphasize that you must actively look for QTc prolongation when patients present with:

  • Syncope (unexplained loss of consciousness)
  • Seizures (often misdiagnosed as a primary seizure disorder when actually arrhythmic)
  • Resuscitated cardiac arrest
  • Family history of unexplained sudden death 1

Critical Clinical Context

Most patients with QTc prolongation remain completely asymptomatic until a catastrophic arrhythmic event occurs. This is why the condition is so dangerous—there's often no warning before TdP develops. The risk of malignant ventricular arrhythmias correlates directly with the degree of QT prolongation 1.

When Arrhythmias Develop

When QTc prolongation progresses to actual arrhythmia, the sequence typically unfolds as:

  1. Torsades de pointes (polymorphic ventricular tachycardia with characteristic "twisting" QRS complexes)
  2. This can degenerate into ventricular fibrillation
  3. Leading to syncope (if self-terminating) or sudden cardiac death (if sustained) 1

Risk Thresholds

The guidelines specify that arrhythmia risk increases substantially when:

  • QTc exceeds 500 ms, or
  • QTc increases by >60-70 ms from baseline, particularly when this increase develops rapidly 1

Important Clinical Pitfalls

Do not assume that absence of symptoms means absence of risk. Even asymptomatic patients with documented QTc prolongation benefit from preventative measures including β-blocker therapy (in congenital LQTS), avoidance of QT-prolonging drugs, and maintenance of normal electrolytes 1.

Be aware that seizure-like activity may actually represent arrhythmic syncope. Patients with unexplained "seizures" warrant ECG evaluation to rule out LQTS as the underlying cause 1.

After cardiac arrest, QTc can remain artificially prolonged for several days due to cooling, myocardial injury, and CNS effects. Serial ECGs are required to avoid overdiagnosis of LQTS in this setting 1.

High-Risk Populations

Women, elderly patients, and those with underlying structural heart disease face higher risk of symptomatic arrhythmias when QTc prolongation occurs 1. Life-threatening complications (VT, TdP, sudden cardiac death) occur in approximately 5% of patients who develop drug-induced QTc prolongation 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.